These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11902137)

  • 1. Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?
    Ungerstedt JS; Schulman S; Egberg N; Antovic J; Blombäck N
    Blood; 2002 Mar; 99(6):2271-2. PubMed ID: 11902137
    [No Abstract]   [Full Text] [Related]  

  • 2. Detecting antithrombin deficiency may be a difficult task--more than one test is necessary.
    Kristensen SR; Rasmussen B; Pedersen S; Bathum L
    J Thromb Haemost; 2007 Mar; 5(3):617-8. PubMed ID: 17229050
    [No Abstract]   [Full Text] [Related]  

  • 3. The progressive antithrombin (antithrombin-III, heparin-cofactor).
    Pálos LA
    Haematologia (Budap); 1974; 8(1-4):455-9. PubMed ID: 4461431
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antithrombin deficiency in the healthy population.
    Tait RC; Walker ID; Perry DJ; Islam SI; Daly ME; McCall F; Conkie JA; Carrell RW
    Br J Haematol; 1994 May; 87(1):106-12. PubMed ID: 7947234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THROMBOPHILIA CAUSED BY INHERITABLE DEFICIENCY OF BLOOD ANTITHROMBIN.
    EGEBERG O
    Scand J Clin Lab Invest; 1965; 17():92. PubMed ID: 14260761
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular basis of antithrombin deficiency in four Japanese patients with antithrombin gene abnormalities including two novel mutations.
    Kyotani M; Okumura K; Takagi A; Murate T; Yamamoto K; Matsushita T; Sugimura M; Kanayama N; Kobayashi T; Saito H; Kojima T
    Am J Hematol; 2007 Aug; 82(8):702-5. PubMed ID: 17492649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two novel mutations of the antithrombin gene observed in Japanese thrombophilic patients.
    Kurihara M; Watanabe K; Inoue S; Wada Y; Ono M; Wakiyama M; Iida H; Kinoshita S; Hamasaki N
    Thromb Res; 2005; 115(5):351-8. PubMed ID: 15733967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A South African family with antithrombin III deficiency.
    Beukes CA; Heyns AD
    S Afr Med J; 1980 Sep; 58(13):528-30. PubMed ID: 7423286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for testing APC resistance in thrombophilic patients.
    Sochynsky CL; Joyner A; Ortel TI
    Am Clin Lab; 1994 Jul; 13(7):26-7. PubMed ID: 10147384
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombin assay - the use of human or bovine thrombin and the observation of a "second" heparin cofactor.
    Friberger P; Egberg N; Holmer E; Hellgren M; Blombäck M
    Thromb Res; 1982 Mar; 25(5):433-6. PubMed ID: 7071813
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin niigata: a novel missense mutation (Thr194-Ile) of the antithrombin gene results in type I deficiency.
    Fuse I; Ozawa T; Higuchi W; Aizawa Y
    Thromb Haemost; 2000 Dec; 84(6):1126. PubMed ID: 11154130
    [No Abstract]   [Full Text] [Related]  

  • 16. [Type I hereditary antithrombin deficiency due to C2757T heterozygotic mutation in antithrombin gene].
    Zhou RF; Dai Q; Fu QH; Wang WB; Xue S; Ding QL; Hu YQ; Wang XF; Wang HL
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1640-2. PubMed ID: 16185535
    [No Abstract]   [Full Text] [Related]  

  • 17. THE DETERMINATION OF BLOOD GLUTATHIONE.
    MORTENSEN E
    Scand J Clin Lab Invest; 1965; 17():93-4. PubMed ID: 14260762
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombin-3 deficiency in a Dutch family.
    van der Meer J; Stoepman-van Dalen EA; Jansen JM
    J Clin Pathol; 1973 Jul; 26(7):532-8. PubMed ID: 4199363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
    Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral hemorrhage associated with a novel antithrombin gene mutation in a neonate.
    Baud O; Picard V; Durand P; Duchemin J; Proulle V; Alhenc-Gelas M; Devictor D; Dreyfus M
    J Pediatr; 2001 Nov; 139(5):741-3. PubMed ID: 11713457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.